All public logs
Jump to navigation
Jump to search
Combined display of all available logs of HemOnc.org - A Hematology Oncology Wiki. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
(newest | oldest) View (newer 250 | older 250) (20 | 50 | 100 | 250 | 500)- 15:05, 26 November 2023 Jwarner talk contribs moved page Allogeneic HSCT to Allogeneic HSCT conditioning regimens over redirect
- 15:05, 26 November 2023 Jwarner talk contribs deleted redirect Allogeneic HSCT conditioning regimens by overwriting (Deleted to make way for move from "Allogeneic HSCT")
- 13:55, 26 November 2023 Jwarner talk contribs moved page Niraparib and Abiraterone (Akeega) to Niraparib and abiraterone (Akeega)
- 03:09, 26 November 2023 Jwarner talk contribs moved page Mycostatin (Nystatin) to Nystatin (Mycostatin) (error in brand naming)
- 18:15, 19 November 2023 Jwarner talk contribs created page Category:PARP2 inhibitors (Created page with "Category:PARP inhibitors")
- 18:15, 19 November 2023 Jwarner talk contribs created page Category:PARP1 inhibitors (Created page with "Category:PARP inhibitors")
- 18:05, 19 November 2023 Jwarner talk contribs created page Category:TYK2 inhibitors (Created page with "A member of the Janus kinase family of tyrosine kinases. Category:JAK inhibitors")
- 14:14, 18 November 2023 Jwarner talk contribs moved page Toripalimab (Loqtorz) to Toripalimab (Loqtorzi) (Brand name not spelled right)
- 15:10, 17 November 2023 Jwarner talk contribs created page Category:Aromatase inhibitors, third generation (Created page with "Category:Aromatase inhibitors")
- 15:09, 17 November 2023 Jwarner talk contribs created page Category:Aromatase inhibitors, second generation (Created page with "Category:Aromatase inhibitors")
- 15:08, 17 November 2023 Jwarner talk contribs created page Category:Aromatase inhibitors, first generation (Created page with "Category:Aromatase inhibitors")
- 15:03, 17 November 2023 Jwarner talk contribs created page Category:PMDA approved in 1995 (Created page with "Category:PMDA approved drugs")
- 14:26, 17 November 2023 Jwarner talk contribs moved page Anlotinib (AL-3818) to Anlotinib (Fukewei) (brand name)
- 12:32, 17 November 2023 Jwarner talk contribs moved page Capivasertib (AZD-5363) to Capivasertib (Truqap) (FDA approval)
- 11:50, 17 November 2023 Jwarner talk contribs created page Thyroid cancer, medullary - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 20:16, 15 November 2023 Jwarner talk contribs created page NCCN guidelines (Created page with "This page will be a gathering place for the National Comprehensive Cancer Network (NCCN) guidelines that do not clearly fit under a disease-specific page. '''Given the rapid...")
- 00:44, 13 November 2023 Jwarner talk contribs created page Upper tract urothelial carcinoma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 20:12, 7 November 2023 Jwarner talk contribs created page Category:EMA approved in 1977 (Created page with "Category:EMA approved drugs")
- 17:12, 7 November 2023 Jwarner talk contribs moved page Bacillus Calmette-Guérin (BCG) to BCG vaccine (INN)
- 01:28, 7 November 2023 Jwarner talk contribs created page CRC (Redirected page to Colorectal cancer) Tag: New redirect
- 01:00, 7 November 2023 Jwarner talk contribs created page Category:Warm autoimmune hemolytic anemia medications (Created page with "Category:Classical hematology medications")
- 00:59, 7 November 2023 Jwarner talk contribs created page Category:EMA approved in 1955 (Created page with "Category:EMA approved drugs")
- 00:55, 7 November 2023 Jwarner talk contribs created page Category:Colorectal cancer medications (historic) (Created page with "Category:Colorectal cancer medications")
- 23:16, 6 November 2023 Jwarner talk contribs created page Category:Acquired hemophilia A medications (Created page with "Category:Acquired coagulopathy medications")
- 20:57, 6 November 2023 Jwarner talk contribs created page Mitomycin pyelocalyceal (Jelmyto) (Created page with "==Mechanism of action== Antibiotic oncologic isolated from Streptomyces caespitosus; inhibits DNA synthesis and induces crosslinking. Formulated for pyelocalyceal infusion. =...")
- 20:28, 6 November 2023 Jwarner talk contribs created page Lasofoxifene (Fablyn) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lasofoxifene NCI Drug Dictionary]: A non-steroidal, naphthalene-derived, thi...")
- 20:08, 6 November 2023 Jwarner talk contribs created page Fadrozole (Afema) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fadrozole-hydrochloride NCI Data Dictionary]: The hydrochloride salt of the...")
- 19:33, 6 November 2023 Jwarner talk contribs created page Dinutuximab beta (Qarziba) (Created page with "==Mechanism of action== Anti-GD2 antibody ==Diseases for which it is used== *Neuroblastoma ==History of changes in EMA indication== *2017-05-08: Initial authorisation as...")
- 19:04, 6 November 2023 Jwarner talk contribs created page Chlorozotocin (DCNU) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorozotocin NCI Drug Dictionary]: A glucose-linked chloroethylnitrosourea...")
- 18:59, 6 November 2023 Jwarner talk contribs created page Trastuzumab-zerc (Zercepac) (Created page with "'''Note: this is a trastuzumab biosimilar.''' ==Also known as== *'''Brand name:''' Zercepac Category:Drugs Category:Intravenous medications Category:Neutral C...")
- 18:59, 6 November 2023 Jwarner talk contribs created page Trastuzumab-herw (Herwenda) (Created page with "'''Note: this is a trastuzumab biosimilar.''' ==Also known as== *'''Brand name:''' Herwenda Category:Drugs Category:Intravenous medications Category:Neutral C...")
- 18:58, 6 November 2023 Jwarner talk contribs created page Rituximab-rixi (Riximyo) (Created page with "'''Note: this is a rituximab biosimilar.''' ==Also known as== *'''Brand name:''' Riximyo Category:Drugs Category:Intravenous medications Category:Neutral Cate...")
- 18:58, 6 November 2023 Jwarner talk contribs created page Rituximab-rixa (Rixathon) (Created page with "'''Note: this is a rituximab biosimilar.''' ==Also known as== *'''Brand name:''' Rixathon Category:Drugs Category:Intravenous medications Category:Neutral Cat...")
- 18:58, 6 November 2023 Jwarner talk contribs created page Rituximab-rite (Ritemvia) (Created page with "'''Note: this is a rituximab biosimilar.''' ==Also known as== *'''Brand name:''' Ritemvia Category:Drugs Category:Intravenous medications Category:Neutral Cat...")
- 18:58, 6 November 2023 Jwarner talk contribs created page Rituximab-blit (Blitzima) (Created page with "'''Note: this is a rituximab biosimilar.''' ==Also known as== *'''Brand name:''' Blitzima Category:Drugs Category:Intravenous medications Category:Neutral Cat...")
- 18:57, 6 November 2023 Jwarner talk contribs created page Bevacizumab-onbe (Onbevzi) (Created page with "'''Note: this is a bevacizumab biosimilar.''' ==Also known as== *'''Brand name:''' Onbevzi Category:Drugs Category:Intravenous medications Category:Neutral Ca...")
- 18:56, 6 November 2023 Jwarner talk contribs created page Bevacizumab-equi (Equidacent) (Created page with "'''Note: this is a bevacizumab biosimilar.''' ==Also known as== *'''Brand name:''' Equidacent Category:Drugs Category:Intravenous medications Category:Neutral [...")
- 18:56, 6 November 2023 Jwarner talk contribs created page Bevacizumab-aybi (Aybintio) (Created page with "'''Note: this is a bevacizumab biosimilar.'' ==Also known as== *'''Brand name:''' Aybintio Category:Drugs Category:Intravenous medications Category:Neutral Ca...")
- 13:59, 6 November 2023 Jwarner talk contribs created page Anlotinib (AL-3818) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/catequentinib-hydrochloride NCI Drug Dictionary]: The hydrochloride salt for...")
- 12:15, 6 November 2023 Jwarner talk contribs created page Cutaneous squamous cell carcinoma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 13:04, 5 November 2023 Jwarner talk contribs created page Systemic mastocytosis - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:54, 5 November 2023 Jwarner talk contribs created page Polycythemia vera - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:12, 5 November 2023 Jwarner talk contribs created page Meningioma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:07, 5 November 2023 Jwarner talk contribs created page B-cell lymphoma of mucosa-associated lymphoid tissue - historical (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:00, 5 November 2023 Jwarner talk contribs created page B-cell lymphoma of mucosa-associated lymphoid tissue - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 11:36, 5 November 2023 Jwarner talk contribs created page JMML (Redirected page to Juvenile myelomonocytic leukemia) Tag: New redirect
- 00:14, 4 November 2023 Jwarner talk contribs moved page Fruquintinib (HMPL-013) to Fruquintinib (Elunate) (brand name)
- 20:52, 3 November 2023 Jwarner talk contribs created page Acute lymphoblastic leukemia, infant - historical (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 20:49, 3 November 2023 Jwarner talk contribs created page Category:Acute lymphoblastic leukemia, infant regimens (Created page with "Category:Acute lymphoblastic leukemia regimens")
- 20:48, 3 November 2023 Jwarner talk contribs created page Acute lymphoblastic leukemia, infant (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 00:37, 1 November 2023 Jwarner talk contribs created page Merkel cell carcinoma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 10:59, 31 October 2023 Jwarner talk contribs created page Motixafortide (Aphexda) (Created page with "cyclic-peptide CXCR4 inhibitor Category:Drugs Category:CXCR4 inhibitor Category:FDA approved in 2023 Category:Stub")
- 23:34, 28 October 2023 Jwarner talk contribs created page Category:Anti-CLDN18.2 antibodies (Created page with "Category:Antineoplastic monoclonal antibodies")
- 23:33, 28 October 2023 Jwarner talk contribs created page Category:Gastric cancer medications (investigational) (Created page with "Category:Gastric cancer medications")
- 23:33, 28 October 2023 Jwarner talk contribs created page Zolbetuximab (IMAB-362) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zolbetuximab NCI Drug Dictionary]: A chimeric immunoglobulin G1 (IgG1) monoc...")
- 21:53, 28 October 2023 Jwarner talk contribs created page Fitusiran (ALN-AT3SC) (Created page with "==Mechanism of action== siRNA therapeutic, targets antithrombin ==Preliminary data== ===Inherited coagulopathy=== #'''ATLAS-A/B:''' Srivastava A, Rangarajan S, Kavakli K,...")
- 21:34, 28 October 2023 Jwarner talk contribs created page Hepatic veno-occlusive disease - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 21:31, 28 October 2023 Jwarner talk contribs created page Category:Hepatic veno-occlusive disease regimens (Created page with "Regimens with some demonstrated degree of efficacy in the treatment of hepatic veno-occlusive disease.")
- 21:30, 28 October 2023 Jwarner talk contribs created page Hepatic veno-occlusive disease (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 00:45, 26 October 2023 Jwarner talk contribs created page ASCO guidelines (Created page with "This page will be a gathering place for the American Society of Clinical Oncology (ASCO) guidelines that do not clearly fit under a disease-specific page. '''Given the rapid...")
- 00:51, 25 October 2023 Jwarner talk contribs created page Myelodysplastic syndrome, IDH-mutated (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 23:32, 24 October 2023 Jwarner talk contribs created page Category:KFDA approved in 2021 (Created page with "Category:KFDA approved drugs")
- 23:31, 24 October 2023 Jwarner talk contribs created page Lazertinib (Leclaza) (Created page with "==General information== Class/mechanism from the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lazertinib NCI Drug Dictionary]: An orally available third-g...")
- 22:44, 15 October 2023 Jwarner talk contribs created page ESMO guidelines (Created page with "This page will be a gathering place for ESMO guidelines that do not clearly fit under a disease-specific page. =Fertility & Pregnancy= *'''2013:''' Peccatori et al. [https://...")
- 20:38, 14 October 2023 Jwarner talk contribs created page Tenosynovial giant cell tumor - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 20:34, 14 October 2023 Jwarner talk contribs created page Subependymal giant cell astrocytoma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:08, 14 October 2023 Jwarner talk contribs created page Myelodysplastic syndrome - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 14:42, 11 October 2023 Jwarner talk contribs created page PJP Prophylaxis (Created page with "The purpose of this page is to list the various types of PJP prophylaxis in common usage. ==Guidelines== ==Prophylaxis== ===Trimethoprim-Sulfamethoxazole (Bactrim DS)|Tri...")
- 20:55, 3 October 2023 Jwarner talk contribs created page Category:Anti-Factor IXa/Factor Xa bispecific antibodies (Created page with "Category:Bispecific antibody medications")
- 20:55, 3 October 2023 Jwarner talk contribs created page Category:Anti-EGFR/HGFR bispecific antibodies (Created page with "Category:Bispecific antibody medications")
- 20:50, 3 October 2023 Jwarner talk contribs moved page Category:Anti-GPRC5D bispecific T-cell engager antibodies to Category:Anti-GPRC5D/CD3 bispecific antibodies
- 20:47, 3 October 2023 Jwarner talk contribs moved page Category:Anti-EpCAM bispecific T-cell engager antibodies to Category:Anti-EpCAM/CD3 bispecific antibodies
- 20:45, 3 October 2023 Jwarner talk contribs moved page Category:Anti-CD33 bispecific T-cell engager antibodies to Category:Anti-CD33/CD3 bispecific antibodies
- 20:45, 3 October 2023 Jwarner talk contribs moved page Category:Anti-CD19 bispecific T-cell engager antibodies to Category:Anti-CD19/CD3 bispecific antibodies
- 20:43, 3 October 2023 Jwarner talk contribs moved page Category:Anti-CD20 bispecific T-cell engager antibodies to Category:Anti-CD20/CD3 bispecific antibodies
- 20:40, 3 October 2023 Jwarner talk contribs moved page Category:Anti-BCMA bispecific T-cell engager antibodies to Category:Anti-BCMA/CD3 bispecific antibodies
- 19:56, 3 October 2023 Jwarner talk contribs created page Category:Small bowel adenocarcinoma medications (Created page with "Category:Gastrointestinal oncology medications")
- 22:20, 1 October 2023 Jwarner talk contribs created page Category:PMDA approved in 1981 (Created page with "Category:PMDA approved drugs")
- 22:15, 1 October 2023 Jwarner talk contribs created page Category:Loop diuretics (Created page with "Category:Diuretics")
- 21:45, 1 October 2023 Jwarner talk contribs created page Category:Light-chain (AL) amyloidosis medications (investigational) (Created page with "Category:Light-chain (AL) amyloidosis medications")
- 15:22, 29 September 2023 Jwarner talk contribs moved page Folinic acid (Leucovorin) to Leucovorin (Folinic acid) (Alignment with INN)
- 20:13, 26 September 2023 Jwarner talk contribs created page Germ cell tumor (Created page with "At this point we do not have a dedicated page for germ cell tumors. More information about this broad class of tumors can be found [https://en.wikipedia.org/wiki/Germ_cell_tum...")
- 15:22, 23 September 2023 Jwarner talk contribs created page Category:Malignant neoplasm (Created page with "Category:Condition")
- 14:30, 23 September 2023 Jwarner talk contribs created page Category:TGF-beta inhibitors (Created page with "Category:Erythrocyte growth factors")
- 14:24, 23 September 2023 Jwarner talk contribs created page Category:Urate oxidase (Created page with "Category:Uric acid lowering agents")
- 12:16, 23 September 2023 Jwarner talk contribs created page Category:Synthetic muramyl dipeptides (Created page with "Category:Immunotherapeutic")
- 11:51, 23 September 2023 Jwarner talk contribs created page Category:GnRH analogs (Created page with "Category:Endocrine therapeutic")
- 11:27, 23 September 2023 Jwarner talk contribs created page Category:JAK3 inhibitors (Created page with "Category:JAK inhibitors")
- 11:25, 23 September 2023 Jwarner talk contribs created page Category:JAK1 inhibitors (Created page with "Category:JAK inhibitors")
- 11:24, 23 September 2023 Jwarner talk contribs created page Category:JAK2 inhibitors (Created page with "Category:JAK inhibitors")
- 00:29, 23 September 2023 Jwarner talk contribs created page Category:Anti-IL-2R immunotoxins (Created page with "Category:Immunotoxin")
- 00:12, 23 September 2023 Jwarner talk contribs created page Category:Topoisomerase II inhibitors (Created page with "Category:Topoisomerase inhibitors")
- 23:38, 22 September 2023 Jwarner talk contribs moved page Category:SMO or PTCH-1 (Hedgehog) medications to Category:Malignant solid neoplasm, SMO-mutated or PTCH-1-mutated (Hedgehog) medications
- 23:37, 22 September 2023 Jwarner talk contribs moved page SMO or PTCH-1 (Hedgehog) to Malignant solid neoplasm, SMO-mutated or PTCH-1-mutated (Hedgehog)
- 23:37, 22 September 2023 Jwarner talk contribs moved page Category:SMO or PTCH-1 (Hedgehog) regimens to Category:Malignant solid neoplasm, SMO-mutated or PTCH-1-mutated (Hedgehog) regimens
- 23:33, 22 September 2023 Jwarner talk contribs moved page Category:TMB-H medications to Category:Malignant solid neoplasm, TMB-H medications
- 23:32, 22 September 2023 Jwarner talk contribs moved page TMB-H to Malignant solid neoplasm, TMB-H
- 23:32, 22 September 2023 Jwarner talk contribs moved page Category:TMB-H regimens to Category:Malignant solid neoplasm, TMB-H regimens
- 23:31, 22 September 2023 Jwarner talk contribs moved page Category:RET medications to Category:Malignant solid neoplasm, RET-mutated medications
- 23:30, 22 September 2023 Jwarner talk contribs moved page RET to Malignant solid neoplasm, RET-mutated
- 23:29, 22 September 2023 Jwarner talk contribs moved page Category:RET regimens to Category:Malignant solid neoplasm, RET-mutated regimens
- 23:37, 21 September 2023 Jwarner talk contribs created page Category:Malignant solid neoplasm, NTRK-mutated medications (Created page with "Medications with some degree of efficacy in the treatment of NTRK-mutated solid tumors, regardless of anatomic site of origin. Ca...")
- 23:33, 21 September 2023 Jwarner talk contribs moved page Category:NTRK regimens to Category:Malignant solid neoplasm, NTRK-mutated regimens
- 23:32, 21 September 2023 Jwarner talk contribs moved page NTRK to Malignant solid neoplasm, NTRK-mutated
- 23:24, 21 September 2023 Jwarner talk contribs moved page Category:MSI-H or dMMR medications to Category:Malignant solid neoplasm, MSI-H or dMMR medications
- 23:23, 21 September 2023 Jwarner talk contribs moved page Category:MSI-H or dMMR regimens to Category:Malignant solid neoplasm, MSI-H or dMMR regimens
- 23:22, 21 September 2023 Jwarner talk contribs moved page MSI-H or dMMR to Malignant solid neoplasm, MSI-H or dMMR
- 21:48, 21 September 2023 Jwarner talk contribs moved page ERBB3 (HER3) to Malignant solid neoplasm, ERBB3-mutated
- 21:48, 21 September 2023 Jwarner talk contribs moved page Category:ERBB3 (HER3) regimens to Category:Malignant solid neoplasm, ERBB3-mutated regimens
- 21:07, 21 September 2023 Jwarner talk contribs moved page Category:ERBB3 (HER3) medications to Category:Malignant solid neoplasm, ERBB3-mutated medications
- 21:07, 21 September 2023 Jwarner talk contribs moved page Category:ERBB2 (HER2) medications to Category:Malignant solid neoplasm, ERBB2-mutated medications
- 21:05, 21 September 2023 Jwarner talk contribs moved page Category:ERBB2 (HER2) regimens to Category:Malignant solid neoplasm, ERBB2-mutated regimens
- 21:04, 21 September 2023 Jwarner talk contribs moved page ERBB2 (HER2) to Malignant solid neoplasm, ERBB2-mutated
- 16:27, 21 September 2023 Jwarner talk contribs moved page Category:Solid malignant neoplasm, EGFR-mutated regimens to Category:Malignant solid neoplasm, EGFR-mutated regimens
- 16:27, 21 September 2023 Jwarner talk contribs moved page Solid malignant neoplasm, EGFR-mutated to Malignant solid neoplasm, EGFR-mutated
- 16:26, 21 September 2023 Jwarner talk contribs moved page Category:Solid malignant neoplasm, EGFR-mutated medications to Category:Malignant solid neoplasm, EGFR-mutated medications
- 16:07, 21 September 2023 Jwarner talk contribs moved page Category:EGFR medications to Category:Solid malignant neoplasm, EGFR-mutated medications
- 16:04, 21 September 2023 Jwarner talk contribs moved page Category:EGFR regimens to Category:Solid malignant neoplasm, EGFR-mutated regimens
- 16:03, 21 September 2023 Jwarner talk contribs moved page EGFR to Solid malignant neoplasm, EGFR-mutated
- 15:15, 21 September 2023 Jwarner talk contribs moved page Category:BRAF medications to Category:Malignant solid neoplasm, BRAF-mutated medications
- 15:13, 21 September 2023 Jwarner talk contribs moved page Category:BRAF regimens to Category:Malignant solid neoplasm, BRAF-mutated regimens
- 15:12, 21 September 2023 Jwarner talk contribs moved page BRAF to Malignant solid neoplasm, BRAF-mutated
- 23:43, 18 September 2023 Jwarner talk contribs created page Category:Anti-dabigatran antibody fragments (Created page with "Category:Anticoagulant reversal agents")
- 23:43, 18 September 2023 Jwarner talk contribs created page Category:Anticoagulant reversal agents (Created page with "Category:Classical hematology medications")
- 23:43, 18 September 2023 Jwarner talk contribs created page Category:Heparin antagonist (Created page with "Category:Anticoagulant reversal agents")
- 23:30, 18 September 2023 Jwarner talk contribs created page Category:Small bowel carcinoma medications (Created page with "Category:Gastrointestinal oncology medications")
- 23:28, 18 September 2023 Jwarner talk contribs created page Category:Folic acid analog (Created page with "Category:Potentiating agents Category:Chemotherapy protective agents")
- 23:27, 18 September 2023 Jwarner talk contribs created page Category:Potentiating agents (Created page with "A category of drugs that potentiate the effect of another drug or localized intervention. Category:Drugs")
- 15:20, 15 September 2023 Jwarner talk contribs created page Category:Anti-CD7 CAR T-cells (Created page with "Category:Chimeric antigen receptor T-cells")
- 15:20, 15 September 2023 Jwarner talk contribs created page Category:T-cell acute lymphoblastic leukemia medications (investigational) (Created page with "Category:T-cell acute lymphoblastic leukemia medications")
- 15:19, 15 September 2023 Jwarner talk contribs created page BE-CAR7 (Created page with "==Mechanism of action== Base-edited ("off the shelf") CAR T-cells directed against CD7 ==Preliminary data== #Chiesa R, Georgiadis C, Syed F, Zhan H, Etuk A, Gkazi SA, Preece...")
- 14:55, 15 September 2023 Jwarner talk contribs created page Category:Cereblon E3 ubiquitin ligase modulators (Created page with "Category:Enzyme inhibitors")
- 14:54, 15 September 2023 Jwarner talk contribs created page Mezigdomide (BMS-986348) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mezigdomide NCI Drug Dictionary]: A modulator of the E3 ubiquitin ligase com...")
- 16:44, 13 September 2023 Jwarner talk contribs created page Category:Topoisomerase I inhibitors (Created page with "Category:Topoisomerase inhibitors")
- 16:41, 13 September 2023 Jwarner talk contribs created page Category:Alkyl sulfonates (Created page with "Category:Alkylating agents")
- 19:23, 9 September 2023 Jwarner talk contribs created page Category:Urothelial carcinoma medications (investigational) (Created page with "Category:Urothelial carcinoma medications")
- 13:44, 9 September 2023 Jwarner talk contribs created page Category:Urothelial carcinomas (Created page with "Category:Genitourinary cancers")
- 12:35, 9 September 2023 Jwarner talk contribs created page Category:Urothelial carcinoma medications (Created page with "Medications which have been shown to have some degree of efficacy in the treatment of urothelial carcinoma. Category:Genitourinary oncology medications")
- 12:21, 9 September 2023 Jwarner talk contribs created page Category:Urothelial carcinoma regimens (Created page with "Category:Genitourinary (GU) oncology regimens")
- 12:16, 9 September 2023 Jwarner talk contribs created page Urothelial carcinoma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:04, 9 September 2023 Jwarner talk contribs moved page Bladder cancer - historical to Urothelial carcinoma - historical
- 11:53, 9 September 2023 Jwarner talk contribs moved page Bladder cancer to Urothelial carcinoma
- 16:31, 7 September 2023 Jwarner talk contribs moved page Olverembatinib (HQP1351) to Olverembatinib (HQP-1351) (naming standardization)
- 01:25, 7 September 2023 Jwarner talk contribs created page How I Treat (Created page with "The "How I Treat" series has been published by ''Blood'' for several decades and covers a wide variety of topics in malignant and classical hematology. While these articles ar...")
- 20:59, 5 September 2023 Jwarner talk contribs created page Category:Small bowel carcinoma regimens (Created page with "Category:Gastrointestinal (GI) oncology regimens")
- 20:58, 5 September 2023 Jwarner talk contribs created page Small bowel adenocarcinoma (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:09, 4 September 2023 Jwarner talk contribs moved page Eculizumab (Epysqli) to Eculizumab-epys (Epysqli) (Biosimilar naming convention)
- 12:08, 4 September 2023 Jwarner talk contribs moved page Eculizumab (Bekemv) to Eculizumab-beke (Bekemv) (Biosimilar naming convention)
- 12:02, 4 September 2023 Jwarner talk contribs created page Eculizumab (Bekemv) (Created page with "==General information== Class/mechanism: Complement inhibitor; monoclonal antibody that binds to complement protein C5, preventing its cleavage to C5a and C5b and the formatio...")
- 12:02, 4 September 2023 Jwarner talk contribs created page Eculizumab (Epysqli) (Created page with "==General information== Class/mechanism: Complement inhibitor; monoclonal antibody that binds to complement protein C5, preventing its cleavage to C5a and C5b and the formatio...")
- 20:11, 3 September 2023 Jwarner talk contribs created page Category:Anti-TFPI antibodies (Created page with "Category:Hematologic monoclonal antibodies")
- 20:11, 3 September 2023 Jwarner talk contribs created page Concizumab (Alhemo) (Created page with "Anti-TFPI antibody ==Supporting data== *'''explorer7:''' Matsushita T, Shapiro A, Abraham A, Angchaisuksiri P, Castaman G, Cepo K, d'Oiron R, Frei-Jones M, Goh AS, Haaning J,...")
- 11:15, 30 August 2023 Jwarner talk contribs created page Category:ACVR1 inhibitors (Created page with "A class of drugs that inhibit activin A receptor, type I (ACVR1). Category:Serine/threonine kinase inhibitors")
- 10:45, 30 August 2023 Jwarner talk contribs created page Category:Myelodysplastic syndrome medications (investigational) (Created page with "Category:Myelodysplastic syndrome medications")
- 23:31, 29 August 2023 Jwarner talk contribs created page Breast cancer, triple negative - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 18:47, 29 August 2023 Jwarner talk contribs created page Breast cancer, ER-positive - historical (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:19, 27 August 2023 Jwarner talk contribs created page Breast cancer, ER-positive - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 01:01, 27 August 2023 Jwarner talk contribs created page Breast cancer, HER2-positive - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 11:29, 24 August 2023 Jwarner talk contribs created page Divarasib (GDC-6036) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divarasib NCI Drug Dictionary]: An orally available inhibitor of the oncogen...")
- 23:19, 17 August 2023 Jwarner talk contribs created page Category:Statins (Created blank page)
- 23:19, 17 August 2023 Jwarner talk contribs created page Simvastatin (Zocor) (Created page with "A statin with possible antileukemic properties. ==Also known as== *'''Brand name:''' Zocor Category:Drugs Category:Oral medications Category:Statins Category:F...")
- 21:05, 17 August 2023 Jwarner talk contribs created page MZL (Redirected page to Marginal zone lymphoma) Tag: New redirect
- 21:03, 16 August 2023 Jwarner talk contribs created page Melphalan for Injection/Hepatic Delivery System (Hepzato Kit) (Created page with "==General information== Class/mechanism: Nitrogen mustard, alkylator ==Diseases for which it is established== *Uveal melanoma ==History of changes in FDA indication== *2...")
- 11:19, 16 August 2023 Jwarner talk contribs created page Olverembatinib (HQP1351) (Created page with "==Mechanism of action== Third-generation TKI ==Diseases for which it is used== *Chronic myeloid leukemia ==History of changes in NMPA indication== *2021-11: Initial cond...")
- 12:22, 15 August 2023 Jwarner talk contribs created page Large language model pilot (Created page with "We are conducting a pilot of generative artificial intelligence to create human-readable synopses for some of the most relevant anticancer regimens on HemOnc.org. The goal of...")
- 18:52, 14 August 2023 Jwarner talk contribs created page Elranatamab (Elrexfio) (Created page with "==General information== Class/mechanism from the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elranatamab NCI Drug Dictionary]: A bispecific monoclonal an...")
- 12:47, 12 August 2023 Jwarner talk contribs created page Niraparib and Abiraterone (Akeega) (Created page with "==Mechanism of action== A fixed dose combination of niraparib and abiraterone. Niraparib inhibits poly(ADP-ribose) polymerase (PARP) enzymes PARP-1 and PARP-2, which are invol...")
- 02:23, 11 August 2023 Jwarner talk contribs moved page Tislelizumab (BGB-A317) to Tislelizumab (Baizean) (brand name)
- 02:13, 11 August 2023 Jwarner talk contribs moved page Zimberelimab (AB-122) to Zimberelimab (Yu Duo) (brand name)
- 14:42, 10 August 2023 Jwarner talk contribs moved page Talquetamab (JNJ-64407564) to Talquetamab (Talvey) (FDA approval)
- 14:00, 3 August 2023 Jwarner talk contribs created page Donafenib (Zepsun) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/donafenib NCI Drug Dictionary]: An orally available multikinase inhibitor th...")
- 18:18, 2 August 2023 Jwarner talk contribs created page Category:Aggressive non-Hodgkin lymphomas (Created page with "Category:Aggressive lymphomas")
- 14:12, 1 August 2023 Jwarner talk contribs created page Category:Interferon gammas (Created page with "Category:Interferons")
- 14:10, 1 August 2023 Jwarner talk contribs created page Category:Interferon alfas (Created page with "Category:Interferons")
- 01:52, 26 July 2023 Jwarner talk contribs created page Category:NMPA approved in 2009 (Created page with "Category:NMPA approved drugs")
- 01:52, 26 July 2023 Jwarner talk contribs created page Realgar-Indigo naturalis formulation (Created page with "==Mechanism of action== From [https://en.wikipedia.org/wiki/Realgar/Indigo_naturalis Wikipedia]: The basic action of this medication is similar to arsenic trioxide in that the...")
- 01:48, 26 July 2023 Jwarner talk contribs created page Histamine dihydrochloride (Ceplene) (Created page with "==Mechanism of action== From [https://en.wikipedia.org/wiki/Histamine_dihydrochloride Wikipedia]: Histamine dihydrochloride acts by improving the immune-enhancing properties o...")
- 00:39, 26 July 2023 Jwarner talk contribs created page Trofosfamide (Ixoten) (Created page with "''Note: this drug appears to only be approved in Germany.'' Nitrogen mustard, alkylating agent Category:Drugs Category:Oral medications [[Category:Alkylating agents]...")
- 00:34, 26 July 2023 Jwarner talk contribs created page Temoporfin (Foscan) (Created page with "==Mechanism of action== Photosensitizer ==Diseases for which it is used== *Head and neck cancer Category:Drugs Category:Intravenous medications Category:Photos...")
- 00:32, 26 July 2023 Jwarner talk contribs created page Category:Anti-NGcGM3 antibodies (Created page with "Category:Immunostimulatory monoclonal antibodies")
- 00:31, 26 July 2023 Jwarner talk contribs created page Racotumomab (Vaxira) (Created page with "''This drug is currently approved in Argentina and Cuba.'' ==Mechanism of action== From [https://en.wikipedia.org/wiki/Racotumomab Wikipedia]: Racotumomab is an anti-idiotypic...")
- 00:23, 26 July 2023 Jwarner talk contribs created page Padeliporfin (Tookad) (Created page with "==Mechanism of action== Photosensitizer ==Diseases for which it is used== *Prostate cancer Category:Drugs Category:Photosensitizers Category:Prostate cancer me...")
- 00:20, 26 July 2023 Jwarner talk contribs created page Mifamurtide (Mepact) (Created page with "==Mechanism of action== Fully synthetic derivative of muramyl dipeptide (MDP) ==Diseases for which it is used== *Osteosarcoma ==History of changes in EMA indication== *2...")
- 17:12, 25 July 2023 Jwarner talk contribs created page Category:Craniopharyngioma medications (Created page with "Category:Neurooncology medications")
- 17:10, 25 July 2023 Jwarner talk contribs created page Category:Craniopharyngioma regimens (Created page with "Category:Neurooncology regimens")
- 17:10, 25 July 2023 Jwarner talk contribs created page Craniopharyngioma (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 14:05, 24 July 2023 Jwarner talk contribs created page Category:Low-grade glioma medications (investigational) (Created page with "Category:Low-grade glioma medications")
- 14:05, 24 July 2023 Jwarner talk contribs created page Vorasidenib (AG-881) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorasidenib NCI Drug Dictionary]: An orally available inhibitor of mutated f...")
- 06:03, 23 July 2023 Jwarner talk contribs created page ASPS (Redirected page to Alveolar soft part sarcoma) Tag: New redirect
- 06:00, 23 July 2023 Jwarner talk contribs created page Category:Alveolar soft part sarcoma regimens (Created page with "Category:Soft tissue sarcoma regimens")
- 06:00, 23 July 2023 Jwarner talk contribs created page Alveolar soft part sarcoma (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 05:44, 23 July 2023 Jwarner talk contribs created page Category:Inflammatory myofibroblastic tumor medications (Created page with "Category:Soft tissue sarcoma medications")
- 05:42, 23 July 2023 Jwarner talk contribs created page Category:Inflammatory myofibroblastic tumor regimens (Created page with "Category:Soft tissue sarcoma regimens")
- 05:41, 23 July 2023 Jwarner talk contribs created page Inflammatory myofibroblastic tumor (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 00:02, 23 July 2023 Jwarner talk contribs created page Sitagliptin (Januvia) (Created page with "Category:Drugs Category:Stub")
- 04:57, 9 July 2023 Jwarner talk contribs created page Category:Photosensitizers (Created page with "A class of drugs that act as potentiating agents when exposed to certain wavelengths of light.")
- 12:26, 4 July 2023 Jwarner talk contribs moved page Category:Anti-IL3 immunotoxins to Category:IL-3 fused immunotoxins
- 12:21, 4 July 2023 Jwarner talk contribs created page Category:Anti-IL3 immunotoxins (Created page with "Category:Immunotoxin")
- 10:40, 4 July 2023 Jwarner talk contribs created page Category:Progestins (Created page with "Category:Endocrine therapeutic")
- 10:38, 4 July 2023 Jwarner talk contribs moved page Medroxyprogesterone (MPA) to Medroxyprogesterone acetate (MPA)
- 10:31, 4 July 2023 Jwarner talk contribs created page Category:Factor B inhibitors (Created page with "Category:Complement pathway inhibitors")
- 10:29, 4 July 2023 Jwarner talk contribs created page Category:NMPA approved in 2011 (Created page with "Category:NMPA approved drugs")
- 09:27, 4 July 2023 Jwarner talk contribs created page Category:Pyruvate kinase activator (Created page with "Category:Enzyme activator")
- 23:53, 3 July 2023 Jwarner talk contribs created page Category:NMPA approved in 2019 (Created page with "Category:NMPA approved drugs")
- 23:53, 3 July 2023 Jwarner talk contribs moved page Flumatinib (HH-GV-678) to Flumatinib (Xinfu) (NMPA approval)
- 22:28, 3 July 2023 Jwarner talk contribs created page Category:Anti-CD22 immunotoxins (Created page with "Category:Anti-CD22 antibodies")
- 21:47, 3 July 2023 Jwarner talk contribs created page Category:Health Canada approved in 1994 (Created page with "Category:Health Canada approved drugs")
- 21:44, 3 July 2023 Jwarner talk contribs created page Category:Asparagine-specific enzymes (Created page with "Category:Enzymes")
- 09:38, 1 July 2023 Jwarner talk contribs moved page Category:Iron to Category:Iron replacement
- 09:35, 1 July 2023 Jwarner talk contribs created page Category:IMPDH inhibitors (Created page with "Category:Immunosuppressants")
- 09:08, 1 July 2023 Jwarner talk contribs created page Category:Interleukins (Created page with "Category:Cytokines")
- 21:28, 30 June 2023 Jwarner talk contribs created page Category:Anti-HER2 antibody-drug conjugates (Created page with "Category:Antibody-drug conjugates Category:Anti-HER2 antibodies")
- 21:21, 30 June 2023 Jwarner talk contribs created page Category:Anti-TF antibody-drug conjugates (Created page with "Category:Antibody-drug conjugates Category:Anti-TF antibodies")
- 21:20, 30 June 2023 Jwarner talk contribs created page Category:Anti-TACSTD2 antibody-drug conjugates (Created page with "Category:Antibody-drug conjugates Category:Anti-TACSTD2 antibodies")
- 21:19, 30 June 2023 Jwarner talk contribs created page Category:Anti-CD79B antibody-drug conjugates (Created page with "Category:Antibody-drug conjugates Category:Anti-CD79B antibodies")
- 21:18, 30 June 2023 Jwarner talk contribs created page Category:Anti-FOLR1 antibody-drug conjugates (Created page with "Category:Antibody-drug conjugates Category:Anti-FOLR1 antibodies")
- 21:17, 30 June 2023 Jwarner talk contribs created page Category:Anti-CD22 antibody-drug conjugates (Created page with "Category:Antibody-drug conjugates Category:Anti-CD22 antibodies")
- 21:16, 30 June 2023 Jwarner talk contribs created page Category:Anti-nectin-4 antibody-drug conjugates (Created page with "Category:Antibody-drug conjugates Category:Anti-nectin-4 antibodies")
- 21:13, 30 June 2023 Jwarner talk contribs created page Category:Anti-CD3 BiTE antibodies (Created page with "Category:BiTE antibodies Category:Anti-CD3 antibodies")
- 21:11, 30 June 2023 Jwarner talk contribs created page Category:Anti-CD19 antibody-drug conjugates (Created page with "Category:Antibody-drug conjugates Category:Anti-CD19 antibodies")
- 21:10, 30 June 2023 Jwarner talk contribs created page Category:Anti-CD30 antibody-drug conjugates (Created page with "Category:Antibody-drug conjugates Category:Anti-CD30 antibodies")
- 21:09, 30 June 2023 Jwarner talk contribs created page Category:Anti-BCMA antibody-drug conjugates (Created page with "Category:Antibody-drug conjugates Category:Anti-BCMA antibodies")
- 21:07, 30 June 2023 Jwarner talk contribs created page Category:Anti-CD20 radioimmunoconjugates (Created page with "Category:Radioimmunoconjugate Category:Anti-CD33 antibodies")
- 21:05, 30 June 2023 Jwarner talk contribs created page Category:Anti-CD33 radioimmunoconjugates (Created page with "Category:Radioimmunoconjugates Category:Anti-CD33 antibodies")
- 21:03, 30 June 2023 Jwarner talk contribs created page Category:Anti-CD33 antibody-drug conjugates (Created page with "Category:Antibody-drug conjugates Category:Anti-CD33 antibodies")
- 15:38, 28 June 2023 Jwarner talk contribs created page Category:Anti-GD2 CAR T-cells (Created page with "Category:Chimeric antigen receptor T-cells")
- 15:35, 28 June 2023 Jwarner talk contribs created page Category:Anti-GPRC5D CAR T-cells (Created page with "Category:Chimeric antigen receptor T-cells")
- 15:33, 28 June 2023 Jwarner talk contribs created page Category:Anti-BCMA CAR T-cells (Created page with "Category:Chimeric antigen receptor T-cells")
- 15:33, 28 June 2023 Jwarner talk contribs created page Category:Anti-EGFRvIII CAR T-cells (Created page with "Category:Chimeric antigen receptor T-cells")
- 15:29, 28 June 2023 Jwarner talk contribs created page Category:Anti-CD19 CAR T-cells (Created page with "Category:Chimeric antigen receptor T-cells")
- 15:12, 28 June 2023 Jwarner talk contribs created page Category:Anti-GPRC5D BiTE antibodies (Created page with "Category:BiTE antibodies")
- 15:10, 28 June 2023 Jwarner talk contribs created page Category:Anti-CD20 BiTE antibodies (Created page with "Category:BiTE antibodies")
- 15:09, 28 June 2023 Jwarner talk contribs created page Category:Anti-CD33 BiTE antibodies (Created page with "Category:BiTE antibodies")
- 15:09, 28 June 2023 Jwarner talk contribs created page Category:Anti-EpCAM BiTE antibodies (Created page with "Category:BiTE antibodies")
- 15:07, 28 June 2023 Jwarner talk contribs created page Category:Anti-CD19 BiTE antibodies (Created page with "Category:BiTE antibodies")
- 15:03, 28 June 2023 Jwarner talk contribs created page Category:Anti-BCMA BiTE antibodies (Created page with "Category:BiTE antibodies")
- 12:49, 26 June 2023 Jwarner talk contribs created page Category:NMPA approved in 2022 (Created page with "Category:NMPA approved drugs")
- 12:42, 26 June 2023 Jwarner talk contribs created page Category:NMPA approved in 2018 (Created page with "Category:NMPA approved drugs")
- 12:40, 26 June 2023 Jwarner talk contribs moved page Penpulimab (AK105) to Penpulimab (Anniko) (brand name)
- 12:39, 26 June 2023 Jwarner talk contribs created page Category:NMPA approved in 2021 (Created page with "Category:NMPA approved drugs")
- 12:32, 26 June 2023 Jwarner talk contribs created page Category:NMPA approved in 2020 (Created page with "Category:NMPA approved drugs")
- 13:35, 25 June 2023 Jwarner talk contribs created page Category:Neuroendocrine carcinoma medications (Created page with "Category:Neuroendocrine tumor medications")
- 13:25, 25 June 2023 Jwarner talk contribs created page Category:Neuroendocrine carcinoma regimens (Created page with "Category:Neuroendocrine tumor regimens")
- 13:15, 25 June 2023 Jwarner talk contribs created page Category:Neuroendocrine tumors (Created page with "Category:Endocrine cancers")
- 13:14, 25 June 2023 Jwarner talk contribs created page Neuroendocrine carcinoma (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 13:05, 25 June 2023 Jwarner talk contribs created page Category:Histology-specific pages (Created page with "Pages which contain regimens studied for a particular histology of a traditionally-defined cancer type.")
- 01:17, 25 June 2023 Jwarner talk contribs created page Category:Gamma secretase inhibitor (Created page with "Category:Enzyme inhibitors")
- 01:16, 25 June 2023 Jwarner talk contribs created page Category:Desmoid tumor medications (investigational) (Created page with "Category:Desmoid tumor medications")
- 01:15, 25 June 2023 Jwarner talk contribs created page Nirogacestat (PF-03084014) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nirogacestat NCI Drug Dictionary]: A selective gamma secretase (GS) inhibito...")
- 00:32, 21 June 2023 Jwarner talk contribs moved page Ublituximab (TG-1101) to Ublituximab (Briumvi) (FDA approval)